Related Experiment Video
Updated: Aug 20, 2026
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Determination of apolipoprotein B-48 in serum by a sandwich ELISA
Makoto Kinoshita1, Masaaki Kojima, Teruhiko Matsushima
1Department of Internal Medicine, Teikyo University School of Medicine, Itabashi, Tokyo 173-8605 Japan. makkino@med.teikyo-u.ac.jp
Background:
Apolipoprotein B-48 (apoB-48) is produced by the small intestine, as a part of chylomicrons (CMs), and appears to be a suitable marker for clinical studies of postprandial lipoproteins and related cardiovascular risk factors. We have developed an assay for routine analysis to quantify apoB-48 in serum or plasma.
Methods:
A microtiter plate was coated with monoclonal antibody (4C8) raised against apoB-48 C-terminal specific decapeptide. Serum samples were diluted 100-fold with 0.05 mol/l Tris-HCl buffer (with or without 0.1% Triton X-100). Appropriate calibration curves were obtained in the ELISA by using apoB-48 recombinant antigen.
Results:
No cross-reactivity (<0.001%) was found with apoB-100, as verified by ELISA and Western blot analyses. Intra- and inter-assay CVs were 4.8% and 5.4%, respectively. Recovery of added recombinant apoB-48 in serum was within 94-105%. The assay linearity was intact >5-fold dilution of serum by dilution buffer. ApoB-48 levels in healthy controls (n=18) at fasting were within the range of 2.69-6.56 microg/ml (mean+/-S.D.: 4.60+/-1.54 microg/ml). In healthy subjects, serum apoB-48 concentrations markedly increased in the postprandial state, in parallel with serum triglycerides.
Conclusion:
This method for measuring apoB-48 using the monoclonal antibody 4C8 is simple, reliable and suitable for routine analyses.
